CA

Camino Minerals Corporation

Advancing high-grade copper and precious metal projects from discovery to production.

Overview

Corporate Details

ISIN(s):
CA1380503070
LEI:
549300GNVV79CIRK4R32
Country:
Canada
Address:
666 Burrard Street, V6C 3P6 Vancouver
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Camino Minerals Corporation is a discovery-oriented mineral exploration and development company. It focuses on acquiring and advancing high-grade copper and precious metal projects, with a stated strategy of building a copper platform that spans from discovery to production. The company's portfolio includes key assets such as the Los Chapitos and Maria Cecilia exploration projects. Camino actively engages in exploration activities, including drilling, trenching, and sampling, to identify and define mineral resources for potential future development and mining operations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-16 12:00
Regulatory News Service
Camino Announces High-Grade Copper at Los Chapitos
English 20.9 KB

Automate Your Workflow. Get a real-time feed of all Camino Minerals Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Camino Minerals Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Camino Minerals Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154

Talk to a Data Expert

Have a question? We'll get back to you promptly.